| Summary: | Context: Given the large disease burden of diabetes in Singapore, we felt a need to study the reasons for the low uptake of continuous glucose monitoring (CGM) in Singapore, despite its recognized benefits and international recommendation. Aims: The aim of this article is to identify perceptions of diabetes care providers (DCPs) and extent of barriers to promoting CGM uptake in Singapore. Settings and Design: This is a cross-sectional study in Singapore. Materials and Methods: A cross-sectional online survey of DCPs over 21 years of age, who provided direct outpatient care to diabetes patients in Singapore and spent minimally 50% of their total patient care time on diabetes care services, was conducted. Statistical Analysis Used: K-means cluster analyses grouped respondents by their diabetes technology and CGM attitudes, barriers to employing CGM clinically, and perceived barriers by patients for CGM uptake and adherence. Fisher’s exact tests and Kruskal–Wallis tests assessed for inter-group demographic differences. Results: From a total sample of 47 respondents, analyses formed three clusters, describing DCPs’ willingness to recommend CGM uptake. All respondents agreed cost is the top barrier. Willing (48.9% of sample) and Unwilling (23.4%) DCPs reported minimal and many barriers to employing CGM clinically, respectively, whereas Eager DCPs (27.7%) reported none. Eager and Willing DCPs, who perceived cost as the only barrier by patients, had more positive diabetes technology and CGM attitudes versus the Unwilling DCPs that perceived many barriers by patients. Conclusion: Local DCPs agreed on the role of CGM in optimizing glycemic control, and that cost is the top barrier against CGM uptake.
|
|---|